Clinical Trial Update: Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial updating active reference study of fixed-dose vortioxetine with fluoxetine in children aged 7-11 with major depressive disorder; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)
• Vortioxetine (vortioxetine)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Depressive Disorder, Major | Phase 3 | Status: COMPLETED | Results posted: 2022-09-22